News
What's New
Dr. Holmlund Takes A Seat at the Table in Washington DC
Jan 22, 2012
Dr. Tomas Holmlund has been selected to represent Neurologists from around the country this February in association with the American Academy of Neurology's 2012 Neurology on the Hill. The select few MD's will meet with congressmen and will be lobbying...
Dr. Gupta is the Recipient of the American Association for Geriatric Psychiatry's Clinician of the Year Award
Jan 22, 2012
Dr. Gupta will receive the Geriatric Psychiatry Clinician of the Year Award to be presented at the AAPG Annual Meeting in Washington DC in March 2012. This award is given to a clinician who has demonstrated a profound commitment to...
Dr. Patel Highlighted in this Month's BUFFALO HEALTHY LIVING
Jan 22, 2012
Visit the link below to view Dr. Patel editorial titled "New Hope for MS Patients in Buffalo" (page 17)
http://www.buffalohealthyliving.com/
...
Dr. Jennifer Aubrey Duquin Joins DENT's Concussion Team
Jan 22, 2012
Dr. Aubrey Duquin Joins DENT from the nationally acclaimed Penn State concussion program. ...
Launch of Our New Website
Dec 12, 2011
We welcome you to Dent Institute’s new expanded website! This site is streamlined to help you find the information you need more quickly: Locate our offices with mapped directions, download useful documents and educational material, and meet our specialized providers,...
Platelet Response to Increased Aspirin Dose in Patients Whose Platelets were Non-Responsive to Lower Aspirin Doses (Encore)
Dec 05, 2011
F. Gengo; M.Rainka; E. Westphal; M. Robson; M. Hourihane; V. Bates
The Journal of Clinical Pharmacology; September 2010 :
The most common aspirin dose for secondary stroke prophylaxis is 81 mg daily though current FDA guidelines suggest doses between 50...
Treatment Options for Multiple Sclerosis: Current and Emerging Therapies
Dec 05, 2011
KM. Gawronski; MM Rainka; MJ Patel; FM. Gengo
Pharmacotherapy; Volume 30, Issue 9; September 2010 :
Multiple sclerosis is a chronic autoimmune disease affecting the central nervous system, more specifically, the myelin sheath covering of nerve fibers in the brain...
Neuroimaging in Neuro-Oncology
Dec 05, 2011
Laszlo Mechtler, MD
Neurologic Clinics; Volume 27, Number 1; February 2009 :
The introduction of MRI into clinical practice has been among the most important of all advances in the care of patients with brain tumors. Neuroimaging is no longer a...
Attenuation of Risperidone-Induced Hyperprolactinemia with the Addition of Aripiprazole
Dec 05, 2011
Rainka, MM; Capote, HA; Ross, CA; Gengo, FM
Journal of Clinical Pharmacy and Therapeutics. Volume 24, Issue 5; October 2009 :
Hyperprolactinemia can be a complication of conventional neurolepics as well as risperidone. We report the third case of attenuation...
Neuroimaging of Headaches
Dec 05, 2011
Laszlo L. Mechtler, MD
Continuum Lifelong Learning in Neurology; Volume 14, Number 4; August 2008 :
Imaging for headaches is one of the most frequent and at times challenging decisions a neurologist has to make in the clinical practice of...
The Prevalence of Platelet Nonresponsiveness to Aspirin-Patients Treated for Secondary Stoke Prophylaxis & Patients with Recurrent Ischemic Events
Dec 05, 2011
F. Gengo, M. Rainka, M. Robson, M. Gengo, A. Forrest, M. Hourihane, V. Bates
Journal of Clinical Pharmacology. Volume 48, Number 3; Jan 2008 :
To determine the prevalence of platelet nonresponsiveness to aspirin treatment for secondary stroke prophylaxis, the...
Population Pharmacodynamic Modelling of Aspirin & Ibuprofen
Dec 05, 2011
V. Hong, F. Gengo, M. Rainka, V. Bates, D. MagerClinical Pharmacokinetics; Volume 47, Number 2; 2008 :
The objective of this study was to develop a mechanism-based pharmacodynamic model that characterizes the antiplatelet effects of aspirin (acetylsalicylic acid)...
Effects of Ibuprofen on Magnitude & Duration of Aspirin
Dec 05, 2011
F. Gengo, L. Rubin, M. Robson, M. Rainka, M. Gengo, D. Mager, V. BatesJournal of Clinical Pharmacology; Volume 48, Number 1; Jan 2008 :
This study was designed to measure the magnitude and duration of inhibition of platelet...